10
Dec
2024

LIAONING PHARMACEUTICAL FOREIGN TRADE CORPORATION

Exhibitor at CPHI Middle East 2024 stand 4.A58
About Us

Liaoning Pharmaceutical Foreign Trade Corporation, with a history of over 20 years, is a state-owned pharmaceutical distribution company, which is mainly engaged in new drugs distribution.

Our company's main business include the domestic distribution of new drugs and the exporting of pharmaceutical raw materials, chemicals, intermediates, etc. We have more than 200 suppliers nationwide.

  • CN
  • 2015
    On CPHI since
Company types
Distributor/Import Export
Contact info
  • NO.146 DONGBEI ROAD, DADONG DIST.,SHENYANG, LIAONING, China
Event information
CPHI Middle East 2024
  • 10 Dec 2024 - 12 Dec 2024
  • Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
  • Visit us at stand 4.A58

Products Featured at CPHI Middle East 2024

  • APIs

    Product APIs

    APIs, veterinary materials, food additives, feed additives, chemicals, excipients and medical apparatus. 
  • Herceptin

    Product Herceptin

    Liaoning Pharmaceutical Foreign Trade Corporation offers wide range of pharmaceutical products which includes herceptin. This product is suitable for breast cancer treatment in her2 overexpressing. Contact us for more information.
  • Mabthera

    Product Mabthera

    Liaoning Pharmaceutical Foreign Trade Corporation offers wide range of pharmaceutical products which includes mabthera. It is the world's first to be approved for clinical treatment of non-hodgkin's lymphoma (nhl) is a monoclonal antibody. Contact us for more information.
  • Pegasys

    Product Pegasys

    Liaoning Pharmaceutical Foreign Trade Corporation offers wide range of pharmaceutical products which includes pegasys. It is indicated for the treatment of adults with chronic hepatitis b. Also useful in the treatment of chronic hepatitis c in adult patients. This product is best used in combination with r...
  • Tarceva

    Product Tarceva

    Liaoning Pharmaceutical Foreign Trade Corporation offers wide range of pharmaceutical products which includes tarceva. It applies to at least one chemotherapy regimen for locally advanced or metastatic failure of non-small cell lung cancer. Contact us for more information.